Publications


2016

Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus. 

Lawrenson K, Kar S, McCue K, Kuchenbaeker K, Michailidou K, Tyrer J, Beesley J, Ramus SJ, et al.


Nat Commun
201609
https://pubmed.ncbi.nlm.nih.gov/27601076/

Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Decadence.

Guo Y, Warren Andersen S, Shu XO, Michailidou K, Bolla MK, Wang Q, Garcia-Closas M, Milne RL, et al.


PLoS Med
201608
https://pubmed.ncbi.nlm.nih.gov/27551723/

Worse quality of life in young and recently-diagnosed breast cancer survivors compared to female survivors of other cancers: A cross-sectional study. 

Li J, Humphreys K, Eriksson M, Dar H, Brandberg Y, Hall P, Czene K.


Int J Cancer
201608
https://pubmed.ncbi.nlm.nih.gov/27486698/

An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression.

Wyszynski A, Hong CC, Lam K, Michailidou K, Lytle C, Yao S, Zhang Y, Bolla MK, Wang Q, Dennis J, Hopper JL, Southey MC, Schmidt MK, et al.


Hum Mol Genet
201607
https://pubmed.ncbi.nlm.nih.gov/27402876/

Amount of stroma is associated with mammographic density and stromal expression of oestrogen receptor in normal breast tissues. 

Gabrielson M, Chiesa F, Paulsson J, Strell C, Behmer C, Rönnow K, Czene K, Östman A,  Hall P.


Breast Cancer Res Treat
201606
https://pubmed.ncbi.nlm.nih.gov/27349429/

Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus.

Hisani N. Horne, Charles C. Chung, Han Zhang, Kai Yu, Ludmila Prokunina-Olsson, Kyriaki Michailidou, Manjeet K. Bolla, et al.


PLoS One
201606
https://pubmed.ncbi.nlm.nih.gov/27556229/

Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus. 

Zeng C, Guo X, Long J, Kuchenbaecker KB, Droit A, Michailidou K, Ghoussaini M, Kar S, et al.


Breast Cancer Res
201606
https://pubmed.ncbi.nlm.nih.gov/27459855/

Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers.

Schmidt MK, Hogervorst F, van Hien R, Cornelissen S, Broeks A, Adank MA, Meijers H, Waisfisz Q, Hollestelle A, et al.


J Clin Oncol
201606
https://pubmed.ncbi.nlm.nih.gov/27269948/

RAD51B in Familial Breast Cancer. 

Pelttari LM, Khan S, Vuorela M, Kiiski JI, Vilske S, Nevanlinna V, Ranta S, Schleutker J, et al.


PLoS One
201605
https://pubmed.ncbi.nlm.nih.gov/27149063/

Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer. 

Couch FJ, Kuchenbaecker KB, Michailidou K, Mendoza-Fandino GA, Nord S, Lilyquist J, Olswold C, Hallberg E, et al.


Nat Commun
201604
https://pubmed.ncbi.nlm.nih.gov/27117709/

Association of infertility and fertility treatment with mammographic density in a large screening-based cohort of women: a cross-sectional study.

Frida E. Lundberg, Anna L. V. Johansson, Kenny Rodriguez-Wallberg, Judith S. Brand, Kamila Czene, Per Hall, Anastasia N. Iliadou.


Brest Cancer Res
201604
https://pubmed.ncbi.nlm.nih.gov/27072636/

Infection-related hospitalizations in breast cancer patients: Risk and impact on prognosis. 

Brand JS, Colzani E, Johansson AL, Giesecke J, Clements M, Bergh J, Hall P, Czene K.


J Infect
201604
https://pubmed.ncbi.nlm.nih.gov/27063280/

Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry. 

Zhao Z, Wen W, Michailidou K, Bolla MK, Wang Q, Zhang B, Long J, Shu XO, Schmidt MK, Milne RL, García-Closas M, et al.


Cancer Causes Control
201604
https://pubmed.ncbi.nlm.nih.gov/27053251/

Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170. 

Dunning AM, Michailidou K, Kuchenbaecker KB, Thompson D, French JD, Beesley J, Healey CS, et al.


Nat Genet
201602
https://pubmed.ncbi.nlm.nih.gov/26928228/

No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing.

Easton DF, Lesueur F, Decker B, Michailidou K, Li J, Allen J, Luccarini C, Pooley KA, et al.


J Med Genet
201602
https://pubmed.ncbi.nlm.nih.gov/26921362/

Genetic predisposition to ductal carcinoma in situ of the breast.

Christos Petridis, Mark N. Brook, Vandna Shah, Kelly Kohut, Patricia Gorman, Michele Caneppele, et al.


Breast Cancer Res
201602
https://pubmed.ncbi.nlm.nih.gov/26884359/

2015

A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients.

Seibold P, Schmezer P, Behrens S, Michailidou K, Bolla MK, Wang Q, Flesch-Janys D, et al.


BMC Cancer
201512
https://pubmed.ncbi.nlm.nih.gov/26674097/

Associations of Breast Cancer Risk Prediction Tools With Tumor Characteristics and Metastasis. 

Holm J, Li J, Darabi H, Eklund M, Eriksson M, Humphreys K, Hall P, Czene K.


J Clin Oncol
201511
https://pubmed.ncbi.nlm.nih.gov/26628467/

Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium.

Jieping Lei, Anja Rudolph, Kirsten B. Moysich, Sabine Behrens, Ellen L. Goode, Manjeet K. Bolla, Joe Dennis, Alison M. Dunning, et al.


Hum Genet
201511
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4698282/

SNP-SNP interaction analysis of NF-κB signaling pathway on breast cancer survival. 

Jamshidi M, Fagerholm R, Khan S, Aittomäki K, Czene K, Darabi H, Li J, Andrulis IL, et al.


Oncotarget
201511
https://pubmed.ncbi.nlm.nih.gov/26317411/